Munafa Stock Market Course + Intraday & FNO calls 
APLLTD NEWS why is Alembic Pharmaceuticals Limited price falling or rising
APLLTD NEWS reasons for why stock price of Alembic Pharmaceuticals Limited is falling or rising
APLLTD Alembic Pharmaceuticals is falling or rising technical reasons
Technical analysis forecast of Alembic Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Alembic Pharmaceuticals APLLTD at this time. Stock is rising and might rise more.
It appears as if Alembic Pharmaceuticals APLLTD gave a large move recently.
Stock of Alembic Pharmaceuticals (APLLTD) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of Alembic Pharmaceuticals is bullish for shortterm, and stock might move up till 810 or till 829.2. Use a stoploss of 794.09 and if this stock hits its stoploss, then it can fall down till 778.13
APLLTD Alembic Pharmaceuticals is falling or rising NEWS fundamental reasons
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange about Link of Recording - NEWS as on 2026-02-06
Alembic Pharmaceuticals gets nod for generic Parkinson's treatment tablets Alembic Pharmaceuticals Ltd on Friday said it has received approval from the US health regulator for its generic version of Carbidopa, Levodopa and Entacapone tablets used in treatment of Parkinson's disease. The approval by the US Food & Drug Administrati - NEWS as on 2026-02-06 business-standard.com
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr. Raj Kumar Baheti (DIN: 00332079) as Non-Executive Non-Independent Director of the company w.e.f. April 01, 2026. - NEWS as on 2026-02-05
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication - NEWS as on 2026-02-03
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange about change in Management - NEWS as on 2026-02-01
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 27, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Difluprednate Ophthalmic Emulsion, 0.05%.". - NEWS as on 2026-01-27
Company Announcement Alembic Pharmaceuticals Limited has informed the Exchange about Schedule of meet - NEWS as on 2026-01-21
More announcements and NEWS
APLLTD Alembic Pharmaceuticals Limited current price & indicator signals
Recent prices of APLLTD Alembic Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 10 Tue Feb 2026 | 801.90 | 795.95 to 806.30 | 0.75% | 0.35 times |
| 09 Mon Feb 2026 | 795.95 | 786.60 to 804.00 | -0.21% | 0.6 times |
| 06 Fri Feb 2026 | 797.65 | 776.20 to 808.00 | -1.58% | 1.7 times |
| 05 Thu Feb 2026 | 810.45 | 791.15 to 827.45 | 1.52% | 3.94 times |
| 04 Wed Feb 2026 | 798.35 | 783.00 to 801.00 | 0.85% | 0.56 times |
| 03 Tue Feb 2026 | 791.65 | 787.25 to 814.00 | 1.23% | 0.46 times |
| 02 Mon Feb 2026 | 782.05 | 761.90 to 795.00 | -0.52% | 0.55 times |
| 01 Sun Feb 2026 | 786.15 | 771.00 to 801.10 | 0.38% | 0.44 times |
| 30 Fri Jan 2026 | 783.20 | 752.35 to 788.95 | 2.61% | 0.63 times |
| 29 Thu Jan 2026 | 763.30 | 755.00 to 770.00 | -0.05% | 0.53 times |
| 28 Wed Jan 2026 | 763.70 | 756.00 to 770.00 | 0.85% | 0.59 times |
| 27 Tue Jan 2026 | 757.30 | 744.75 to 765.00 | -0.95% | 0.53 times |
Videos related to: APLLTD NEWS why is Alembic Pharmaceuticals Limited price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
